Advanced cardiovascular assessment, diagnostic evaluation, and catheter-based intervention for patients with diabetes, chronic kidney disease, end-stage renal disease, and multi-system cardiovascular risk.
Standard cardiovascular pathways are frequently inadequate for these populations. Safe and effective care requires subspecialty-level expertise, a precision-guided procedural approach, and a deep understanding of how cardiovascular and systemic disease interact.
Patients with diabetes, chronic kidney disease, or multiple coexisting medical conditions represent some of the highest-risk and most underserved groups in cardiovascular medicine. Their coronary disease is characteristically more diffuse, more heavily calcified, and more anatomically complex. Their physiology makes procedural complications more likely. And the contrast dye used in standard coronary procedures is directly toxic to the kidneys, posing a risk of acute kidney injury that in patients with already-compromised renal function can accelerate progression to dialysis or cause irreversible damage.
The consequences of failing to account for these factors include unnecessary interventions, contrast-induced kidney injury, inadequate calcium modification leading to early stent failure, and the denial of effective treatment to patients considered too high-risk by conventional standards.
This practice has dedicated both clinical expertise and academic research to this patient population, with specific focus on safe coronary intervention in patients with renal impairment and complex systemic disease.
Coronary disease in diabetes is often diffuse, calcified, and multivessel, requiring detailed imaging and physiological assessment to guide treatment and optimise stent delivery.
Dialysis-dependent patients face very high cardiovascular mortality, but careful planning and zero-contrast techniques enable safe, effective coronary intervention.
Complex coronary anatomy with renal disease, diabetes, heart failure, or respiratory disease requires careful planning, physiological assessment, and kidney-protective strategies.
Chronic kidney disease accelerates coronary artery disease and arterial calcification while increasing the risk of contrast-related kidney injury during coronary procedures.
Patients awaiting renal, liver, or multi-organ transplantation require cardiovascular assessment to identify and treat cardiac disease before surgery.
Uncontrolled hypertension can progressively damage the heart and kidneys, requiring specialist evaluation to identify the cause and exclude secondary conditions such as renal artery stenosis.
In patients with diffuse multivessel disease, physiological testing identifies which narrowings are truly limiting blood flow and therefore which lesions warrant treatment. In the context of diabetes and renal disease, where the consequences of both unnecessary and incomplete treatment are amplified, physiology-guided decision-making is particularly important.
Integrated review of clinical history, comorbidity burden, renal function, metabolic profile, and prior investigations to define overall cardiovascular risk and identify the safest diagnostic and treatment pathway for each patient.
High-resolution imaging of the coronary artery wall is fundamental to managing calcified disease in diabetic and renal patients. In zero-contrast procedures, IVUS co-registration replaces angiographic guidance entirely, enabling safe and precise stent implantation without contrast exposure.
Contrast volume is carefully minimised during all coronary procedures in patients with renal impairment, using pre-procedural hydration, strict contrast dose limitation, and in selected cases IVUS co-registration to obtain diagnostic information without contrast exposure.
Coronary intervention in which contrast volume is reduced to a fraction of the standard amount, using IVUS co-registration to guide vessel sizing and stent deployment while substantially reducing the risk of kidney injury.
Coronary intervention performed without any iodinated contrast, guided entirely by intracoronary imaging and physiological assessment. Reserved for patients at highest risk of contrast-induced renal injury, including those with end-stage renal disease. Pioneered in the UAE and published in the Journal of Invasive Cardiology.
Stent implantation guided in real time by intravascular ultrasound, enabling accurate vessel sizing, calcium identification, confirmation of complete stent expansion, and assessment of final stent position.
Treatment limited to lesions confirmed by pressure wire assessment to be haemodynamically significant, reducing procedural risk, contrast exposure, and medication burden in patients with multi-vessel disease and significant comorbidities.
Calcium modification techniques applied to the heavily calcified lesions disproportionately prevalent in diabetic and renal patients. All three are performed at Level 3 independent competence.
Catheter-based assessment and treatment of renal artery stenosis as a contributing cause of resistant hypertension or progressive renal impairment.
Kidney-Protective Coronary Care
Minimal and Zero-Contrast PCI
Complex High-Risk Intervention
Physiology and Imaging Guidance